Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 771

1.

Alpha-synuclein: prion or prion-like?

Leak RK, Frosch MP, Beach TG, Halliday GM.

Acta Neuropathol. 2019 Aug 12. doi: 10.1007/s00401-019-02057-1. [Epub ahead of print] No abstract available.

PMID:
31407028
2.

Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells.

Gao J, Perera G, Bhadbhade M, Halliday GM, Dzamko N.

J Biol Chem. 2019 Aug 2. pii: jbc.RA119.008733. doi: 10.1074/jbc.RA119.008733. [Epub ahead of print]

3.

Parkinson's progression prediction using machine learning and serum cytokines.

Ahmadi Rastegar D, Ho N, Halliday GM, Dzamko N.

NPJ Parkinsons Dis. 2019 Jul 25;5:14. doi: 10.1038/s41531-019-0086-4. eCollection 2019.

4.

CNS cell-type specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.

Ke YD, Chan G, Stefanoska K, Au C, Bi M, Müller J, Przybyla M, Feiten AF, Prikas E, Halliday GM, Piguet O, Kiernan MC, Kassiou M, Hodges JR, Loy CT, Mattick JS, Ittner A, Kril JJ, Sutherland G, Ittner LM.

J Biol Chem. 2019 Jul 31. pii: jbc.RA118.005263. doi: 10.1074/jbc.RA118.005263. [Epub ahead of print]

5.

Reply: LATE to the PART-y.

Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Fardo DW, Flanagan ME, Halliday G, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murray ME, Nag S, Seeley WW, Sperling RA, White CL, Schneider JA.

Brain. 2019 Jul 29. pii: awz226. doi: 10.1093/brain/awz226. [Epub ahead of print] No abstract available.

PMID:
31359039
6.

Correction to: Chronic traumatic encephalopathy in two former Australian National Rugby League players.

Buckland ME, Sy J, Szentmariay I, Kullen A, Lee M, Harding A, Halliday G, Suter CM.

Acta Neuropathol Commun. 2019 Jul 29;7(1):122. doi: 10.1186/s40478-019-0772-9.

7.

Cross-examining candidate genes implicated in multiple system atrophy.

Katzeff JS, Phan K, Purushothuman S, Halliday GM, Kim WS.

Acta Neuropathol Commun. 2019 Jul 24;7(1):117. doi: 10.1186/s40478-019-0769-4. Review.

8.

Neuroinflammation in frontotemporal dementia.

Bright F, Werry EL, Dobson-Stone C, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kassiou M, Kril JJ.

Nat Rev Neurol. 2019 Jul 19. doi: 10.1038/s41582-019-0231-z. [Epub ahead of print] Review.

PMID:
31324897
9.

Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

Lee JS, Kanai K, Suzuki M, Kim WS, Yoo HS, Fu Y, Kim DK, Jung BC, Choi M, Oh KW, Li Y, Nakatani M, Nakazato T, Sekimoto S, Funayama M, Yoshino H, Kubo SI, Nishioka K, Sakai R, Ueyama M, Mochizuki H, Lee HJ, Sardi SP, Halliday GM, Nagai Y, Lee PH, Hattori N, Lee SJ.

Brain. 2019 Jul 15. pii: awz205. doi: 10.1093/brain/awz205. [Epub ahead of print]

PMID:
31312839
10.

Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.

Shehadeh J, Double KL, Murphy KE, Bobrovskaya L, Reyes S, Dunkley PR, Halliday GM, Dickson PW.

Neurobiol Dis. 2019 Oct;130:104524. doi: 10.1016/j.nbd.2019.104524. Epub 2019 Jul 2.

PMID:
31276794
11.

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.

Werry EL, Bright FM, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kril JJ, Kassiou M.

Int J Mol Sci. 2019 Jun 28;20(13). pii: E3161. doi: 10.3390/ijms20133161. Review.

12.

Chronic traumatic encephalopathy in two former Australian National Rugby League players.

Buckland ME, Sy J, Szentmariay I, Kullen A, Lee M, Harding A, Halliday G, Suter CM.

Acta Neuropathol Commun. 2019 Jun 27;7(1):97. doi: 10.1186/s40478-019-0751-1. No abstract available. Erratum in: Acta Neuropathol Commun. 2019 Jul 29;7(1):122. Acta Neuropathol Commun. 2019 Aug 14;7(1):131.

13.

Subtle gait and balance impairments occur in idiopathic rapid eye movement sleep behavior disorder.

Ehgoetz Martens KA, Matar E, Hall JM, Phillips J, Szeto JYY, Gouelle A, Grunstein RR, Halliday GM, Lewis SJG.

Mov Disord. 2019 Jun 26. doi: 10.1002/mds.27780. [Epub ahead of print]

PMID:
31242336
14.

Cellular and regional vulnerability in frontotemporal tauopathies.

Forrest SL, Kril JJ, Halliday GM.

Acta Neuropathol. 2019 Jun 15. doi: 10.1007/s00401-019-02035-7. [Epub ahead of print] Review.

PMID:
31203391
15.

Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients.

Stevens CH, Guthrie NJ, van Roijen M, Halliday GM, Ooi L.

J Neuropathol Exp Neurol. 2019 Jul 1;78(7):605-614. doi: 10.1093/jnen/nlz041.

PMID:
31131395
16.

Von Economo Neurons in Behavioral Variant Frontotemporal Dementia with Underlying Alzheimer's Disease.

Tan RH, Yang Y, McCann H, Shepherd C, Halliday GM.

J Alzheimers Dis. 2019;69(4):963-967. doi: 10.3233/JAD-180900.

PMID:
31104018
17.

Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease.

Olanow CW, Savolainen M, Chu Y, Halliday GM, Kordower JH.

Brain. 2019 Jun 1;142(6):1690-1700. doi: 10.1093/brain/awz104.

PMID:
31056668
18.

Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.

Aoyagi A, Condello C, Stöhr J, Yue W, Rivera BM, Lee JC, Woerman AL, Halliday G, van Duinen S, Ingelsson M, Lannfelt L, Graff C, Bird TD, Keene CD, Seeley WW, DeGrado WF, Prusiner SB.

Sci Transl Med. 2019 May 1;11(490). pii: eaat8462. doi: 10.1126/scitranslmed.aat8462.

PMID:
31043574
19.

Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White Iii CL, Yu L, Schneider JA.

Brain. 2019 Jun 1;142(6):1503-1527. doi: 10.1093/brain/awz099. Erratum in: Brain. 2019 May 31;:.

20.

Impaired Color Discrimination-A Specific Marker of Hallucinations in Lewy Body Disorders.

Matar E, Phillips JR, Martens KAE, Halliday GM, Lewis SJG.

J Geriatr Psychiatry Neurol. 2019 Sep;32(5):257-264. doi: 10.1177/0891988719845501. Epub 2019 Apr 29.

PMID:
31035850
21.

A critique of the second consensus criteria for multiple system atrophy.

Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Höglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK; Movement Disorder Society Multiple System Atrophy Study Group.

Mov Disord. 2019 Jul;34(7):975-984. doi: 10.1002/mds.27701. Epub 2019 Apr 29. No abstract available.

PMID:
31034671
22.

Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease.

Virachit S, Mathews KJ, Cottam V, Werry E, Galli E, Rappou E, Lindholm P, Saarma M, Halliday GM, Shannon Weickert C, Double KL.

Brain Pathol. 2019 Apr 29. doi: 10.1111/bpa.12730. [Epub ahead of print]

PMID:
31033033
23.

Targeted, High-Resolution RNA Sequencing of Non-coding Genomic Regions Associated With Neuropsychiatric Functions.

Hardwick SA, Bassett SD, Kaczorowski D, Blackburn J, Barton K, Bartonicek N, Carswell SL, Tilgner HU, Loy C, Halliday G, Mercer TR, Smith MA, Mattick JS.

Front Genet. 2019 Apr 12;10:309. doi: 10.3389/fgene.2019.00309. eCollection 2019.

24.

Characteristics of animal hoarding cases referred to the RSPCA in New South Wales, Australia.

Elliott R, Snowdon J, Halliday G, Hunt GE, Coleman S.

Aust Vet J. 2019 May;97(5):149-156. doi: 10.1111/avj.12806.

PMID:
31025326
25.

Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.

Forrest SL, Crockford DR, Sizemova A, McCann H, Shepherd CE, McGeachie AB, Affleck AJ, Carew-Jones F, Bartley L, Kwok JB, Kim WS, Jary E, Tan RH, McGinley CV, Piguet O, Hodges JR, Kril JJ, Halliday GM.

Neurology. 2019 May 21;92(21):e2472-e2482. doi: 10.1212/WNL.0000000000007530. Epub 2019 Apr 24.

PMID:
31019099
26.

Heritability and genetic variance of dementia with Lewy bodies.

Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A; International Parkinson's Disease Genomics Consortium, Stone DJ, Bras J.

Neurobiol Dis. 2019 Jul;127:492-501. doi: 10.1016/j.nbd.2019.04.004. Epub 2019 Apr 3.

PMID:
30953760
27.

Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide.

Martin AJ, Dhillon HM, Vardy JL, Dalziell RA, Choy B, Fernández-Peñas P, Dixon A, Renton C, St George G, Chinniah N, Halliday GM, Damian DL, Chen AC.

Geriatrics (Basel). 2019 Mar 25;4(1). pii: E31. doi: 10.3390/geriatrics4010031.

28.

Acute electroconvulsive therapy in the elderly with schizophrenia and schizoaffective disorder: a literature review.

Kumagaya D, Halliday G.

Australas Psychiatry. 2019 Mar 28:1039856219839470. doi: 10.1177/1039856219839470. [Epub ahead of print]

PMID:
30920288
29.

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia.

Ahmed RM, Phan K, Highton-Williamson E, Strikwerda-Brown C, Caga J, Ramsey E, Zoing M, Devenney E, Kim WS, Hodges JR, Piguet O, Halliday GM, Kiernan MC.

Ann Clin Transl Neurol. 2019 Jan 31;6(3):486-495. doi: 10.1002/acn3.721. eCollection 2019 Mar.

30.

The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling.

Crook A, McEwen A, Fifita JA, Zhang K, Kwok JB, Halliday G, Blair IP, Rowe DB.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):310-316. doi: 10.1080/21678421.2019.1588904. Epub 2019 Mar 23.

PMID:
30907153
31.

Dopamine depletion alters macroscopic network dynamics in Parkinson's disease.

Shine JM, Bell PT, Matar E, Poldrack RA, Lewis SJG, Halliday GM, O'Callaghan C.

Brain. 2019 Apr 1;142(4):1024-1034. doi: 10.1093/brain/awz034.

PMID:
30887035
32.

The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability.

Tan RH, Guennewig B, Dobson-Stone C, Kwok JBJ, Kril JJ, Kiernan MC, Hodges JR, Piguet O, Halliday GM.

Neurology. 2019 Mar 19;92(12):e1354-e1366. doi: 10.1212/WNL.0000000000007146. Epub 2019 Feb 15.

PMID:
30770429
33.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, Matchett B, Karydas AM, Hsiung GR, Seelaar H, Mol MO, Finger EC, Graff C, Öijerstedt L, Neumann M, Heutink P, Synofzik M, Wilke C, Prudlo J, Rizzu P, Simon-Sanchez J, Edbauer D, Roeber S, Diehl-Schmid J, Evers BM, King A, Mesulam MM, Weintraub S, Geula C, Bieniek KF, Petrucelli L, Ahern GL, Reiman EM, Woodruff BK, Caselli RJ, Huey ED, Farlow MR, Grafman J, Mead S, Grinberg LT, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Snowden J, Mann D, Ertekin-Taner N, Uitti RJ, Wszolek ZK, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Hodges JR, Piguet O, Geier EG, Yokoyama JS, Rissman RA, Rogaeva E, Keith J, Zinman L, Tartaglia MC, Cairns NJ, Cruchaga C, Ghetti B, Kofler J, Lopez OL, Beach TG, Arzberger T, Herms J, Honig LS, Vonsattel JP, Halliday GM, Kwok JB, White CL 3rd, Gearing M, Glass J, Rollinson S, Pickering-Brown S, Rohrer JD, Trojanowski JQ, Van Deerlin V, Bigio EH, Troakes C, Al-Sarraj S, Asmann Y, Miller BL, Graff-Radford NR, Boeve BF, Seeley WW, Mackenzie IRA, van Swieten JC, Dickson DW, Biernacka JM, Rademakers R.

Acta Neuropathol. 2019 Jun;137(6):879-899. doi: 10.1007/s00401-019-01962-9. Epub 2019 Feb 9.

PMID:
30739198
34.

Heritability in frontotemporal tauopathies.

Forrest SL, Halliday GM, McCann H, McGeachie AB, McGinley CV, Hodges JR, Piguet O, Kwok JB, Spillantini MG, Kril JJ.

Alzheimers Dement (Amst). 2019 Jan 24;11:115-124. doi: 10.1016/j.dadm.2018.12.001. eCollection 2019 Dec.

35.

Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.

Snaidr VA, Damian DL, Halliday GM.

Exp Dermatol. 2019 Feb;28 Suppl 1:15-22. doi: 10.1111/exd.13819. Review.

PMID:
30698874
36.

Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.

Woerman AL, Oehler A, Kazmi SA, Lee J, Halliday GM, Middleton LT, Gentleman SM, Mordes DA, Spina S, Grinberg LT, Olson SH, Prusiner SB.

Acta Neuropathol. 2019 Mar;137(3):437-454. doi: 10.1007/s00401-019-01959-4. Epub 2019 Jan 28.

PMID:
30690664
37.

Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?

Breen DP, Halliday GM, Lang AE.

Mov Disord. 2019 Mar;34(3):307-316. doi: 10.1002/mds.27556. Epub 2019 Jan 17. Review.

PMID:
30653258
38.

Brain Banking for Research into Neurodegenerative Disorders and Ageing.

Shepherd CE, Alvendia H, Halliday GM.

Neurosci Bull. 2019 Apr;35(2):283-288. doi: 10.1007/s12264-018-0326-3. Epub 2019 Jan 2. Review.

PMID:
30604281
39.

LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients.

Atashrazm F, Hammond D, Perera G, Bolliger MF, Matar E, Halliday GM, Schüle B, Lewis SJG, Nichols RJ, Dzamko N.

Mov Disord. 2019 Mar;34(3):406-415. doi: 10.1002/mds.27601. Epub 2018 Dec 30.

PMID:
30597610
40.

Predictors of survival and progression in behavioural variant frontotemporal dementia.

Agarwal S, Ahmed RM, D'Mello M, Foxe D, Kaizik C, Kiernan MC, Halliday GM, Piguet O, Hodges JR.

Eur J Neurol. 2019 May;26(5):774-779. doi: 10.1111/ene.13887. Epub 2019 Jan 29.

PMID:
30565360
41.

Brahma deficiency in keratinocytes promotes UV carcinogenesis by accelerating the escape from cell cycle arrest and the formation of DNA photolesions.

Farrell AW, Halliday GM, Lyons JG.

J Dermatol Sci. 2018 Dec;92(3):254-263. doi: 10.1016/j.jdermsci.2018.11.006. Epub 2018 Nov 22.

PMID:
30522882
42.

Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia.

Kim WS, He Y, Phan K, Ahmed RM, Rye KA, Piguet O, Hodges JR, Halliday GM.

Front Neurosci. 2018 Nov 14;12:847. doi: 10.3389/fnins.2018.00847. eCollection 2018.

43.

Deletion of Alzheimer's Disease Risk Gene ABCA7 Alters White Adipose Tissue Development and Leptin Levels.

Bhatia S, Fu Y, Hsiao JT, Halliday GM, Kim WS.

J Alzheimers Dis Rep. 2017 Dec 16;1(1):237-247. doi: 10.3233/ADR-170029.

44.

Apolipoprotein D Upregulation in Alzheimer's Disease but Not Frontotemporal Dementia.

Bhatia S, Kim WS, Shepherd CE, Halliday GM.

J Mol Neurosci. 2019 Jan;67(1):125-132. doi: 10.1007/s12031-018-1217-9. Epub 2018 Nov 22.

45.

A comprehensive screening of copy number variability in dementia with Lewy bodies.

Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Guerreiro R, Bras J.

Neurobiol Aging. 2019 Mar;75:223.e1-223.e10. doi: 10.1016/j.neurobiolaging.2018.10.019. Epub 2018 Oct 24.

46.

Molecular Pathogenesis of the Tauopathies.

Götz J, Halliday G, Nisbet RM.

Annu Rev Pathol. 2019 Jan 24;14:239-261. doi: 10.1146/annurev-pathmechdis-012418-012936. Epub 2018 Oct 24.

PMID:
30355155
47.

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease.

Atashrazm F, Hammond D, Perera G, Dobson-Stone C, Mueller N, Pickford R, Kim WS, Kwok JB, Lewis SJG, Halliday GM, Dzamko N.

Sci Rep. 2018 Oct 18;8(1):15446. doi: 10.1038/s41598-018-33921-x.

48.

Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease.

Schwartz RS, Halliday GM, Soh D, Cordato DJ, Kril JJ.

J Clin Neurosci. 2018 Dec;58:70-74. doi: 10.1016/j.jocn.2018.10.029. Epub 2018 Oct 14.

PMID:
30327218
49.

Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay.

Baldo B, Sajjad MU, Cheong RY, Bigarreau J, Vijayvargia R, McLean C, Perrier AL, Seong IS, Halliday G, Petersén Å, Kirik D.

eNeuro. 2018 Oct 10;5(4). pii: ENEURO.0234-18.2018. doi: 10.1523/ENEURO.0234-18.2018. eCollection 2018 Jul-Aug.

50.

Psychiatric disorders in C9orf72 kindreds: Study of 1,414 family members.

Devenney EM, Ahmed RM, Halliday G, Piguet O, Kiernan MC, Hodges JR.

Neurology. 2018 Oct 16;91(16):e1498-e1507. doi: 10.1212/WNL.0000000000006344. Epub 2018 Sep 26.

PMID:
30258023

Supplemental Content

Loading ...
Support Center